Insider Trading disclosures for Incyte Corp.

The latest disclosure was made by Barry P. Flannelly in Incyte Corp. where a trade of 461 Common Stock done at an average price of $67.9 was reported to US exchanges on March 14, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Barry P. Flannelly	EVP & General Manager US	Sale of securities on an exchange or to another person at price $ 67.85 per share.	14 Mar 2025	461	52,913 (0%)	0%	67.9	31,279	Common Stock
Barry P. Flannelly	EVP & General Manager US	Sale of securities on an exchange or to another person at price $ 67.68 per share.	14 Mar 2025	19,147	33,567 (0%)	0%	67.7	1,295,869	Common Stock
Barry P. Flannelly	EVP & General Manager US	Sale of securities on an exchange or to another person at price $ 67.88 per share.	14 Mar 2025	199	52,714 (0%)	0%	67.9	13,508	Common Stock
Sheila A Denton	EVP & General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.06 per share.	04 Mar 2025	599	26,447 (0%)	0%	58.1	34,778	Common Stock
Sheila A Denton	EVP & General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Mar 2025	599	18,552	-		-	Employee Stock Option (right to buy)
Sheila A Denton	EVP & General Counsel	Sale of securities on an exchange or to another person at price $ 69.99 per share.	04 Mar 2025	599	25,848 (0%)	0%	70.0	41,924	Common Stock
Sheila A Denton	EVP & General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2025	9,574	19,151	-		-	Employee Stock Option (right to buy)
Sheila A Denton	EVP & General Counsel	Sale of securities on an exchange or to another person at price $ 74.08 per share.	26 Feb 2025	4,495	25,848 (0%)	0%	74.1	332,990	Common Stock
Sheila A Denton	EVP & General Counsel	Sale of securities on an exchange or to another person at price $ 74.07 per share.	26 Feb 2025	9,574	30,343 (0%)	0%	74.1	709,146	Common Stock
Sheila A Denton	EVP & General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.06 per share.	26 Feb 2025	9,574	39,917 (0%)	0%	58.1	555,866	Common Stock
Michael James Morrissey	EVP, Head of Tech. Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	10,552	81,515 (0%)	0%		0	Common Stock
Lee Heeson	EVP, Head of Incyte Intl	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	6,331	32,778 (0%)	0%		0	Common Stock
Michael James Morrissey	EVP, Head of Tech. Operations	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.47 per share.	21 Jan 2025	429	70,963 (0%)	0%	73.5	31,519	Common Stock
Paula J. Swain	EVP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2025	14,772	14,772	-		-	Employee Stock Option (right to buy)
Pablo J. Cagnoni	President, R&D	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2025	40,289	40,289	-		-	Employee Stock Option (right to buy)
Christiana Stamoulis	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2025	25,516	25,516	-		-	Employee Stock Option (right to buy)
Herve Hoppenot	Director, Chairman / CEO, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2025	55,510	55,510	-		-	Employee Stock Option (right to buy)
Barry P. Flannelly	EVP & General Manager US	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2025	20,144	20,144	-		-	Employee Stock Option (right to buy)
Vijay K. Iyengar	EVP, GMAPPS	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2025	14,772	14,772	-		-	Employee Stock Option (right to buy)
Steven H. Stein	EVP & Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 72.69 per share.	17 Jan 2025	12,352	66,967 (0%)	0%	72.7	897,867	Common Stock
Steven H. Stein	EVP & Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2025	28,202	28,202	-		-	Employee Stock Option (right to buy)
Thomas Tray	Principal Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2025	3,432	3,432	-		-	Employee Stock Option (right to buy)
Sheila A Denton	EVP & General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2025	12,086	12,086	-		-	Employee Stock Option (right to buy)
Matteo Trotta	EVP, GM, Dermatology US	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2025	5,371	5,371	-		-	Employee Stock Option (right to buy)
Christiana Stamoulis	EVP & Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.46 per share.	15 Jan 2025	3,672	91,525 (0%)	0%	72.5	266,073	Common Stock
Barry P. Flannelly	EVP & General Manager US	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.46 per share.	15 Jan 2025	3,158	53,374 (0%)	0%	72.5	228,829	Common Stock
Steven H. Stein	EVP & Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.46 per share.	15 Jan 2025	10,692	79,319 (0%)	0%	72.5	774,742	Common Stock
Michael James Morrissey	EVP, Head of Tech. Operations	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.46 per share.	15 Jan 2025	908	71,392 (0%)	0%	72.5	65,794	Common Stock
Mohamed Khairie Issa	EVP, Head of US Oncology	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jan 2025	48,671	48,671 (0%)	0%		0	Common Stock
Paul J. Clancy	Director	Grant, award, or other acquisition of securities at price $ 69.07 per share.	31 Dec 2024	331	19,713 (0%)	0%	69.1	22,862	Common Stock
Edmund P. Harrigan	Director	Grant, award, or other acquisition of securities at price $ 69.07 per share.	31 Dec 2024	339	17,071 (0%)	0%	69.1	23,415	Common Stock
Thomas Tray	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 69.31 per share.	13 Dec 2024	650	23,312 (0%)	0%	69.3	45,052	Common Stock
Thomas Tray	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 70.64 per share.	13 Dec 2024	650	23,962 (0%)	0%	70.6	45,916	Common Stock
Paula J. Swain	EVP, Human Resources	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share.	09 Dec 2024	873	85,203 (0%)	0%	72.1	62,952	Common Stock
Barry P. Flannelly	EVP & General Manager US	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share.	09 Dec 2024	1,510	56,532 (0%)	0%	72.1	108,886	Common Stock
Vijay K. Iyengar	EVP, GMAPPS	Sale of securities on an exchange or to another person at price $ 75.37 per share.	29 Nov 2024	5,683	30,658 (0%)	0%	75.4	428,328	Common Stock
Vijay K. Iyengar	EVP, GMAPPS	Sale of securities on an exchange or to another person at price $ 75.60 per share.	29 Nov 2024	360	36,341 (0%)	0%	75.6	27,216	Common Stock
Barry P. Flannelly	EVP & General Manager US	Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.27 per share.	06 Nov 2024	1,424	59,466 (0%)	0%	72.3	102,912	Common Stock
Barry P. Flannelly	EVP & General Manager US	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Nov 2024	2,256	0	-		-	Employee Stock Option (right to buy)
Barry P. Flannelly	EVP & General Manager US	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Nov 2024	1,424	0	-		-	Employee Stock Option (right to buy)
Barry P. Flannelly	EVP & General Manager US	Sale of securities on an exchange or to another person at price $ 78.21 per share.	06 Nov 2024	2,256	58,042 (0%)	0%	78.2	176,442	Common Stock
Barry P. Flannelly	EVP & General Manager US	Sale of securities on an exchange or to another person at price $ 82.00 per share.	06 Nov 2024	1,424	60,298 (0%)	0%	82	116,768	Common Stock
Barry P. Flannelly	EVP & General Manager US	Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.62 per share.	06 Nov 2024	2,256	61,722 (0%)	0%	68.6	154,807	Common Stock
Sheila A Denton	EVP & General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.63 per share.	02 Oct 2024	2,136	30,343 (0%)	0%	67.6	144,458	Common Stock
Lee Heeson	EVP, Head of Incyte Intl		01 Oct 2024	26,447	26,447 (0%)	0%		0	Common Stock
Paul J. Clancy	Director	Grant, award, or other acquisition of securities at price $ 66.10 per share.	30 Sep 2024	368	19,382 (0%)	0%	66.1	24,325	Common Stock
Edmund P. Harrigan	Director	Grant, award, or other acquisition of securities at price $ 66.10 per share.	30 Sep 2024	378	16,732 (0%)	0%	66.1	24,986	Common Stock
Jonathan Elliott Dickinson	EVP, General Manager, Europe		12 Sep 2024	7,333	36,390 (0%)	0%	62.4	457,359	Common Stock
Jonathan Elliott Dickinson	EVP, General Manager, Europe		12 Sep 2024	1,117	43,723 (0%)	0%	62.3	69,589	Common Stock
Thomas Tray	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 63.37 per share.	12 Sep 2024	382	24,443 (0%)	0%	63.4	24,207	Common Stock

Showing 1 to 50 of 500 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

28.12% Fall from 52W High

Insider Trading disclosures for Incyte Corp.

The latest disclosure was made by Barry P. Flannelly in Incyte Corp. where a trade of 461 Common Stock done at an average price of $67.9 was reported to US exchanges on March 14, 2025.

Screeners based on Insider Trading and SAST parameters